← Back to all clusters

Cluster 60

15 diseases · 35 shared-gene connections
15 Diseases
40 Unique genes
0.302 Avg. similarity score
Mitral valve disease Most-connected disease (9 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
MTHFR 10 / 15 Carotid artery stenosis, Cervical dysplasia, Coronary restenosis, homocystinuria due to methylene tetrahydrofolate reductase deficiency and 6 more
ACE 6 / 15 Coronary restenosis, Fabry disease, Mitral valve disease, renal tubular dysgenesis - ACE and 2 more
POU4F1 4 / 15 Ataxia with intention tremor and hypotonia, Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cervical dysplasia, Uterine disease
GALC 2 / 15 Fabry disease, krabbe disease
MMP3 2 / 15 Carotid artery stenosis, Coronary restenosis
SPP1 2 / 15 Carotid artery stenosis, Coronary restenosis
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Interleukin-4 and Interleukin-13 signaling Reactome 7 / 108 19.5× 5.71e-8 4.01e-6 ✓ sig.
Coronavirus disease - COVID-19 KEGG 7 / 238 8.8× 1.17e-5 3.83e-4 ✓ sig.
Rheumatoid arthritis KEGG 5 / 95 15.8× 1.47e-5 4.63e-4 ✓ sig.
Degradation of the extracellular matrix Reactome 4 / 70 17.2× 8.25e-5 1.92e-3 ✓ sig.
Complement and coagulation cascades KEGG 4 / 88 13.6× 2.01e-4 3.92e-3 ✓ sig.
AGE-RAGE signaling pathway in diabetic complications KEGG 4 / 101 11.9× 3.41e-4 5.93e-3 ✓ sig.
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Reactome 4 / 125 9.6× 7.65e-4 1.11e-2 ✓ sig.
Regulation of TP53 Activity through Association with Co-factors Reactome 2 / 14 42.9× 9.60e-4 1.32e-2 ✓ sig.
Mineral absorption KEGG 3 / 61 14.8× 1.08e-3 1.44e-2 ✓ sig.
Apelin signaling pathway KEGG 4 / 140 8.6× 1.17e-3 1.52e-2 ✓ sig.
Fluid shear stress and atherosclerosis KEGG 4 / 141 8.5× 1.20e-3 1.55e-2 ✓ sig.
Metabolism of Angiotensinogen to Angiotensins Reactome 2 / 17 35.3× 1.43e-3 1.77e-2 ✓ sig.
PPAR signaling pathway KEGG 3 / 76 11.9× 2.03e-3 2.31e-2 ✓ sig.
Pertussis KEGG 3 / 78 11.5× 2.19e-3 2.44e-2 ✓ sig.
Leishmaniasis KEGG 3 / 78 11.5× 2.19e-3 2.44e-2 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
regulation of renal output by angiotensin GO:0002019 2 / 2 467× 4.47e-6 2.74e-4 ✓ sig.
response to glucocorticoid GO:0051384 4 / 53 35.3× 4.89e-6 2.95e-4 ✓ sig.
negative regulation of blood coagulation GO:0030195 3 / 16 87.6× 4.99e-6 3.00e-4 ✓ sig.
positive regulation of calcineurin-NFAT signaling cascade GO:0070886 3 / 21 66.7× 1.18e-5 5.92e-4 ✓ sig.
positive regulation of mitochondrial membrane permeability GO:0035794 2 / 3 311× 1.34e-5 6.55e-4 ✓ sig.
extracellular matrix organization GO:0030198 5 / 145 16.1× 1.39e-5 6.74e-4 ✓ sig.
decidualization GO:0046697 3 / 25 56.1× 2.02e-5 9.06e-4 ✓ sig.
positive regulation of angiogenesis GO:0045766 5 / 159 14.7× 2.17e-5 9.56e-4 ✓ sig.
negative regulation of proteolysis GO:0045861 3 / 27 51.9× 2.56e-5 1.08e-3 ✓ sig.
response to macrophage colony-stimulating factor GO:0036005 2 / 4 234× 2.67e-5 1.12e-3 ✓ sig.
positive regulation of protein-containing complex disassembly GO:0043243 2 / 4 234× 2.67e-5 1.12e-3 ✓ sig.
maintenance of blood vessel diameter homeostasis by renin-angiotensin GO:0002034 2 / 5 187× 4.45e-5 1.65e-3 ✓ sig.
cellular extravasation GO:0045123 2 / 5 187× 4.45e-5 1.65e-3 ✓ sig.
cellular response to lipopolysaccharide GO:0071222 5 / 187 12.5× 4.71e-5 1.72e-3 ✓ sig.
positive regulation of reactive oxygen species metabolic process GO:2000379 3 / 34 41.2× 5.19e-5 1.85e-3 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Rheumatic disease of mitral valve Rheumatic mitral regurgitation 0.667 2 8.44e-9 7.20e-8 ✓ sig.
Cervical dysplasia Uterine disease 0.667 2 8.44e-9 7.20e-8 ✓ sig.
Mitral valve disease Rheumatic mitral regurgitation 0.667 2 8.44e-9 7.20e-8 ✓ sig.
Mitral valve disease Rheumatic disease of mitral valve 0.667 2 8.44e-9 7.20e-8 ✓ sig.
Carotid artery stenosis Coronary restenosis 0.120 3 1.70e-7 1.21e-6 ✓ sig.
Coronary restenosis Mitral valve disease 0.133 2 7.68e-7 4.83e-6 ✓ sig.
Coronary restenosis Rheumatic disease of mitral valve 0.133 2 7.68e-7 4.83e-6 ✓ sig.
Coronary restenosis Rheumatic mitral regurgitation 0.133 2 7.68e-7 4.83e-6 ✓ sig.
homocystinuria due to methylene tetrahydrofolate reductase deficiency Microvascular angina 0.500 1 6.49e-5 2.34e-4 ✓ sig.
homocystinuria due to methylene tetrahydrofolate reductase deficiency Rheumatic mitral regurgitation 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Ataxia with intention tremor and hypotonia Uterine disease 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Microvascular angina Mitral valve disease 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Microvascular angina Rheumatic disease of mitral valve 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Microvascular angina Rheumatic mitral regurgitation 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Mitral valve disease renal tubular dysgenesis - ACE 0.333 1 1.30e-4 3.90e-4 ✓ sig.
renal tubular dysgenesis - ACE Rheumatic disease of mitral valve 0.333 1 1.30e-4 3.90e-4 ✓ sig.
renal tubular dysgenesis - ACE Rheumatic mitral regurgitation 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Microvascular angina Uterine disease 0.333 1 1.30e-4 3.90e-4 ✓ sig.
homocystinuria due to methylene tetrahydrofolate reductase deficiency Uterine disease 0.333 1 1.30e-4 3.90e-4 ✓ sig.
homocystinuria due to methylene tetrahydrofolate reductase deficiency Rheumatic disease of mitral valve 0.333 1 1.30e-4 3.90e-4 ✓ sig.
homocystinuria due to methylene tetrahydrofolate reductase deficiency Mitral valve disease 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Cervical dysplasia homocystinuria due to methylene tetrahydrofolate reductase deficiency 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Cervical dysplasia Microvascular angina 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Ataxia with intention tremor and hypotonia Cervical dysplasia 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Microvascular angina Portal vein thrombosis 0.250 1 1.95e-4 5.28e-4 ✓ sig.
homocystinuria due to methylene tetrahydrofolate reductase deficiency Portal vein thrombosis 0.250 1 1.95e-4 5.28e-4 ✓ sig.
Cervical dysplasia Mitral valve disease 0.250 1 2.60e-4 6.40e-4 ✓ sig.
Mitral valve disease Uterine disease 0.250 1 2.60e-4 6.40e-4 ✓ sig.
Cervical dysplasia Portal vein thrombosis 0.200 1 3.90e-4 8.52e-4 ✓ sig.
Ataxia with intention tremor and hypotonia Cerebellar dysfunction with variable cognitive and behavioral abnormalities 0.143 1 3.90e-4 8.52e-4 ✓ sig.
Fabry disease krabbe disease 0.100 1 5.84e-4 1.14e-3 ✓ sig.
Fabry disease renal tubular dysgenesis - ACE 0.100 1 5.84e-4 1.14e-3 ✓ sig.
Cerebellar dysfunction with variable cognitive and behavioral abnormalities Uterine disease 0.125 1 7.79e-4 1.39e-3 ✓ sig.
Cerebellar dysfunction with variable cognitive and behavioral abnormalities Cervical dysplasia 0.125 1 7.79e-4 1.39e-3 ✓ sig.
Fabry disease Mitral valve disease 0.091 1 1.17e-3 1.88e-3 ✓ sig.